Skip to Main Content

Pinnacle Awards

  • sam patrick posted an article
    Over 500 registered leaders in Charleston celebrate growth, convey recognition on four top honorees see more

    To resounding applause from a record gathering from 6 countries, 26 states and virtually every county in South Carolina, more than 500 life sciences leaders at SCBIO 2022 in Charleston saluted four of their own – three individuals and one organization – for profound positive impact and exceptional contributions to the advancement of South Carolina’s life sciences industry, and the health and advancement of the state.

    Attendees at the sold-out conference, delivered both live and virtually, also learned that South Carolina’s life sciences industry impact has more than doubled since 2016 – to $25.7 billion annually – and its core employment has surged more than 42% in that period despite the pandemic-induced recession of 2020.

    Recipients of the Life Sciences Industry’s PINNACLE awards were the Medical University of South Carolina (MUSC) as Life Sciences Organization of the Year; Dr. Linda Bell, South Carolina state epidemiologist from SC DHEC, as Individual Contributor of the Year; Dr. Martine LaBerge of Clemson University as Life Sciences Hall of Fame recipient; and Ashley Daugherty of Nephron Pharmaceuticals as Rising Star recipient.

    Clemson University’s Dr. Martine LaBerge, chair of the Clemson Department of Bioengineering, was presented with the South Carolina Life Sciences Hall of Fame Award for her personal championing of the life sciences industry, which today has 1,033 firms directly involved and over 87,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental, and agricultural biotechnology products. Clemson University is a Mission Partner of SCBIO and has been highly instrumental in helping the rapid growth of life sciences in the Palmetto State. LaBerge, who joined Clemson in 1990, is the Hall of Fame’s third member, joining former South Carolina Secretary of State Bobby Hitt and Harris Pastides, who was University of South Carolina president from 2008-2019 and recently returned as interim president.

    LaBerge received her Ph.D. in biomedical engineering at the University of Montreal in Quebec and did postdoctoral work at the University of Waterloo in Ontario before joining Clemson as an assistant professor in 1990, where she rose through the ranks, became interim department chair in 2002. Deservedly credited with advancing bioengineering technology and creating interdisciplinary partnerships of scholars, entrepreneurs, and industry leaders to foster innovation, she has helped Clemson establish and strengthen strategic partnerships with the likes of Arthrex, Prisma Health and the Medical University of South Carolina. She also has played a central role in establishing new bioengineering facilities, including the Clemson University Biomedical Engineering Innovation Campus (CUBEInC) in Greenville.

    Presented with the South Carolina Life Sciences Pinnacle Award for Organizational Contribution to the industry was MUSC Health. A Mission Partner of SCBIO, MUSC was saluted for its research, patient care and innovation in the advancement of life sciences and for its contributions during the worst of the COVID pandemic. The MUSC team was honored for its thought leadership, its educational focus in teaching future healthcare providers, its testing and vaccination campaigns to help beat back the pandemic. Accepting the award for MUSC were Dr. Pat Cawley, CEO of MUSC Health and vice president for health affairs of the Medical University of South Carolina; Dr. David Cole, President of MUSC; and Ms. Caroline Brown, Chief External Affairs Officer for MUSC.

    Presented with the South Carolina Life Sciences Pinnacle Award for Individual Contribution to the industry was Dr. Linda Bell, State Epidemiologist and Director of the Bureau of Communicable Disease Prevention and Control for SC DHEC. Dr. Bell has worked in public health for over 28 years as an Epidemic Intelligence Service Officer with the Centers for Disease Control and Prevention with the Viral Special Pathogens Branch and as an EIS field officer. She has served in several positions with SC Department of Health and Environmental Control where, throughout the COVID-19 pandemic, she has been a lead medical advisor in South Carolina providing guidance to help control disease spread for health care

    providers, elected officials, businesses, and the public.

    Dr. Ashley Daugherty serves as Chief Scientific Officer for Nephron Pharmaceuticals, a rapidly growing West-Columbia based pharmaceutical organization. Dr. Daugherty joined Nephron in 2014 as a Chemist and has rapidly risen through the ranks, spending time in analytical services and product development before assuming her current role in 2019. She holds a B.Sc. in Chemistry from the University of South Carolina and her Ph.D. from Emory University in Biomolecular Chemistry. She was honored with the inaugural Rising Star Award for her contributions to product development, advancement of intellectual property initiatives, and her strong and steady leadership during the unprecedented times of the pandemic as Nephron ramped up production, added production lines, and debuted new products and services to meet critical demands of the state and country.

    The four honorees were celebrated by a record 500+ registrants who filled Charleston’s Gaillard Center, with attendees including scores of top industry chief executives, leaders in government and higher education, biotechnology and pharma executives, clinicians and researchers, and industry supporters from across America.

    SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.

    As the official state affiliate of BIO, PhRMA and AdvaMed, SCBIO members include hundreds of academic institutions, biotech companies, medtech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial, and environmental products that transform how we heal, fuel and feed the world.

  • sam patrick posted an article
    Over 140 organizations and hundreds of nation’s industry leaders to gather Feb. 22-24 see more

    SOUTH CAROLINA – January 24, 2022 – Global President & CEO of BIO, Dr. Michelle McMurry-Heath, will be live in Charleston to keynote the opening day of SCBIO 2022, the Life Sciences Conference of South Carolina, conference organizers have announced.

    Dr. McMurry-Heath will join more than 30 additional speakers as featured presenters at the largest life sciences conference in Palmetto State history as the event convenes both in-person and virtually February 22-24 at the Gaillard Center in the heart of Charleston, S.C.

    Themed “Challenge Accepted,” the 2-day SCBIO 2022 event will feature national speaker sessions including Transformational Technologies, Next Generation Patient Care, Ensuring Opportunity for All, and Embracing Collaboration & Innovation – fundamental forces driving the state’s fastest growing industry: life sciences.

    Dr. McMurry-Heath assumed the leadership of BIO as just its third President and CEO in June, 2020. A medical doctor and molecular immunologist by training, she stewards the world’s largest biotechnology advocacy group, representing 1,000 life sciences companies and organizations from 30 countries. The organization’s mission is to support companies that discover and deploy scientific breakthroughs that improve human health, environmental stewardship, and sustainable agriculture.

    She has championed a focus on broadening access to scientific progress so more patients from diverse backgrounds can benefit from cutting-edge innovation, clinical trials and healthcare funding, a topic she terms “the social justice issue of our age.” She joined BIO from Johnson & Johnson where she served as Global Head of Evidence Generation for Medical Device Companies and then Vice President of Global External Innovation and Global Leader for Regulatory Sciences. She was also instrumental in bringing J&J’s incubator, JLabs, to Washington, DC. She led a global team of 900 with responsibilities in 150 countries around the globe.

    Presented by sponsoring organizations Nephron Pharmaceuticals, Vikor Scientific, Revaly (a Zverse Solution) and other top organizations, the conference is expected to draw a sell-out attendance of 450 in person attendees and hundreds more virtually to Charleston.  Attendees will be required to present proof of vaccination or a negative Covid test result within 72 hours of arrival before being admitted.

    Among other top speakers scheduled to appear include FDA Associate Director of the CDER Drug Shortage Staff Valerie Jensen MUSC Health CEO Dr. Pat Cawley, Velocity Clinical Research executive Steve Clemons, and USC Provost Dr. Stephen Cutler, Clemson University President James Clements, Commerce Secretary Harry Lightsey III, Nephron CEO Lou Kennedy, PhRMA Senior Policy Director Courtney Christian, Georgia Health Information Network Director Dr. Denise Hines, State Epidemiologist Dr. Linda Bell and more than 20 others.

    National economist Dr. Joseph Von Nessen of University of South Carolina’s Moore School of Business will report findings of a just-completed economic impact study of the state’s life sciences cluster, last analyzed in 2017, while SCBIO CEO James Chappell will present a State of the Industry presentation on the outlook for South Carolina’s $12 billion – and fastest-growing – industry.

    The conference features an expanded – and nearly sold out -- exhibit hall showcasing scores of life sciences industry businesses, institutions of higher learning and essential support industry partners from across America.  The conference also features presentation of the prestigious Pinnacle Awards by South Carolina Life Sciences to the outstanding 2021 Organization of the Year, Individual of the Year, and Rising Star under 40 years of age, as well as a new recipient into the SC Life Sciences Hall of Fame.  

    Hundreds of in-person and virtual attendees will take advantage of meetings and connection sessions through the conference’s Partnering Portal as well as at two gala receptions planned for attendees.

    Registration to attend SCBIO 2022 is now open at the 2022 Annual Conference section of www.scbio.org for interested companies, industry supporters, students interested in life sciences, faculty and teachers. Limited Exhibit  space and sponsorships are still available by inquiring at info@scbio.org.

    The 2-day conference draws attendees from across America for networking, innovation updates, opportunity discovery, partnership making and strategic discussion. Already committed attendees include officials across a broad spectrum of life sciences industries including medical devices, bio manufacturing, drug discovery, R&D, pharmaceuticals, diagnostics and testing, digital health and health IT, bio-ag and more.

    SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has more than 700 firms directly involved and over 43,000 professionals employed directly or indirectly in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental, and agricultural biotechnology products.  In 2021, Governor Henry McMaster issued an Executive Order making it a state priority to continue to grow and expand the life sciences industry in the Palmetto State.

    Among 140 leading biotech and med-tech industry brands participating in the conference are Nephron Pharmaceuticals, Vikor Scientific, Zverse, BIO, Johnson & Johnson, AVX, PhRMA, Medpoint, AdvaMed, Poly-Med, VWR, Rhythmlink, SoftBox Systems, ZEUS, Patheon Thermo Fisher, Abbott, Alcami and more. All of South Carolina’s research universities – MUSC, Clemson and the University of South Carolina – are represented, as are major healthcare systems, and economic development entities including the South Carolina Department of Commerce, SCRA, South Carolina Hospital Association and others.

    For additional information on SCBIO or to register for SCBIO 2021, visit www.SCBIO.org.

  • sam patrick posted an article
    Hundreds of nation’s industry leaders to gather for strategic partnership development, insights see more

    With the biggest story of 2021 – the global COVID-19 pandemic – serving as a backdrop, the largest life sciences conference in Palmetto State history will convene both in-person and virtually February 22-24 to address how South Carolina and America are accepting the challenge of  achieving health and prosperity for all, South Carolina life sciences industry officials have announced.

    Themed “Challenge Accepted,” the 2-day SCBIO 2022 event will feature national speaker sessions on Transformational Technologies, Next Generation Patient Care, Ensuring Opportunity for All, and Embracing Collaboration & Innovation – fundamental forces driving the state’s fastest growing industry: life sciences.

    Currently listed as a $12 billion industry, national economist Dr. Joseph Von Nessen of University of South Carolina’s Moore School of Business will report findings of a just-completed economic impact study of the state’s life sciences cluster, last analyzed in 2017.

    FDA Associate Director of the CDER Drug Shortage Staff Valerie Jensen is the first announced featured major speaker for the 2-day conference, addressing the gathering in a Program “Challenge Accepted:  Delivering Next Generation Care to Patients Now.”  A trained clinical pharmacist, Captain Jensen was one of the initial developers of FDA’s Drug Shortage Program and was named Associate Director in 2012. She continues to manage the Drug Shortage Staff at FDA. Joined by MUSC Health CEO Dr. Pat Cawley, Velocity Clinical Research executive Steve Clemons, and USC Provost Dr. Stephen Cutler, the panel will focus on the industry’s success in to expediting development of medicine, devices, technologies and vaccines in record time and with startling efficacy – and what it means for care around the world going forward.

    Captain Jensen will be joined by more than 25 additional presenters and honorees at SCBIO 2022, which brings together leaders and executives from life science organizations across the nation to South Carolina. In deference to the pandemic, FDA protocols on safety are being rigorously adhered to and events are also being presented and distributed virtually, organizers revealed.

    The conference will feature a significantly expanded exhibit hall showcasing scores of life sciences industry businesses, institutions of higher learning and essential support industry partners from across America, as well as presentation of the prestigious Pinnacle Awards by South Carolina Life Sciences to the outstanding 2021 Organization of the Year and Individual of the Year. Also to be honored with Pinnacle Awards will be an inductee into the SC Life Sciences Hall of Fame, and an award for an industry Rising Star under 40 years of age.  

    New SCBIO CEO James Chappell will deliver a highly anticipated “State of South Carolina’s Life Sciences Industry” address, while hundreds of in-person and virtual attendees will take advantage of meetings and connection sessions through the conference’s Partnering Portal. Additional speakers will be announced shortly, as well as posted online.

    Registration to attend the 2-day conference is now open online.  For more details, visit the 2022 Annual Conference section at www.scbio.org. Registration and exhibiting are free to many SCBIO investors. Early bird general admission pricing provides significant discounts to interested companies, industry supporters, students interested in life sciences, faculty and teachers. Limited Exhibit  space and sponsorships are also available by inquiring at info@scbio.org.

    The 2-day conference annually draws attendees from across America for networking, innovation updates, opportunity discovery, partnership making and strategic discussion. Already committed attendees include officials across a broad spectrum of life sciences industries including medical devices, bio manufacturing, drug discovery, R&D, pharmaceuticals, diagnostics and testing, digital health and health IT, bio-ag and more.

    SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has more than 700 firms directly involved and over 43,000 professionals employed directly or indirectly in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental, and agricultural biotechnology products.  In early 2021, Governor Henry McMaster issued an Executive Order making it a state priority to continue to grow and expand the life sciences industry in the Palmetto State.

    “Life sciences is a major driver of South Carolina’s economy, and this conference’s growth is testament to the industry’s surging impact, reach and rapidly rising economic significance in our state and region,” noted SCBIO President and CEO James Chappell. “Already accounting for thousands of highly-skilled jobs in the Palmetto State, this sector has tremendous growth potential, and we’re excited to showcase top companies, research universities and leaders from across our state and country at SCBIO 2022.” 

    Among leading biotech and med-tech industry brands participating in the conference are Nephron Pharmaceuticals, BIO, Johnson & Johnson, AVX, PhRMA, Medpoint, AdvaMed, Poly-Med, VWR, Rhythmlink, SoftBox Systems, ZEUS, Patheon Thermo Fisher, Zverse, Abbott, Alcami and more. All of South Carolina’s research universities – MUSC, Clemson and the University of South Carolina – are represented, as are major healthcare systems, and economic development entities including the South Carolina Department of Commerce, SCRA, South Carolina Hospital Association and others.

    As the official state affiliate of BIO, PhRMA and AdvaMed, SCBIO members include academic institutions, biotech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products that transform how we heal, fuel and feed the world.

    For additional information on SCBIO or to register for SCBIO 2021, visit www.SCBIO.org.

  • sam patrick posted an article
    SCBIO 2021 to feature top national speakers on SC Life Sciences Feb. 16-17 see more

    The Power of Us Conference features virtual format with top speakers, virtual partnering sessions, industry awards and virtual exhibit hall; CEOs and top industry leaders from 30+ states and countries expected for strategic partnership development, industry insights.

     

    SOUTH CAROLINA – January 11, 2021 – With the biggest story of 2020 – the global COVID-19 pandemic – serving as the backdrop, the biggest life sciences conference in Palmetto State history will convene virtually February 16-17 to address how South Carolina and America will once again achieve health and prosperity, South Carolina life sciences industry officials announced today.

    Themed “The Power of Us,” the 2-day SCBIO 2021 event will feature national speaker sessions on The Power of Innovation, The Power of Partnership, and The Power of People – each a fundamental force which drives the state’s surging $12 billion industry that is a key contributor to South Carolina’s expanding knowledge economy.

    Biotechnology Innovation Organization (BIO) President and CEO Dr. Michelle McMurry-Heath is the first announced featured speaker for the 2-day conference, addressing the virtual gathering about the critical importance of The Power of People, and how diversity, equality and inclusion are essential ingredients to true collaboration and discovery – as has been borne out during development of COVID-19 vaccines.

    A medical doctor and molecular immunologist by training, Dr. McMurry-Heath was named CEO of BIO in 2020 after time with Johnson & Johnson where she served as Global Head of Evidence Generation for Medical Device Companies and then Vice President of Global External Innovation and Global Leader for Regulatory Sciences. She was also instrumental in expansion of J&J’s incubator, JLabs, to Washington, DC; is the founding director of the Aspen Institute’s Health, Biomedical Science, and Society Policy Program; and received her MD/PhD from Duke’s Medical Scientist Training Program, becoming the first African American to graduate from the prestigious program. She also spent 12 years working at the research bench before taking policy and leadership roles in government and industry.

     Dr. McMurry-Heath will be joined by more than a dozen additional presenters and honorees at SCBIO 2021 – the annual conference which annually brings together leaders and executives from life sciences organizations across the nation to South Carolina.  In deference to the pandemic, all events are being conducted safely in a virtual format, organizers revealed.

    The conference will also feature a virtual exhibit hall showcasing scores of life sciences industry businesses, institutions of higher learning and essential support industry partners from across the country, as well as presentation of the prestigious Pinnacle Awards by South Carolina Life Sciences to the outstanding 2020 Organization of the Year and Individual of the Year.  SCBIO CEO Sam Konduros will deliver the highly anticipated “State of South Carolina’s Life Sciences Industry” address, while hundreds of virtual attendees are expected to take advantage of meetings and connection sessions through the conference’s Partnering Portal.  Additional speakers will be announced shortly, as well as posted online.

    Registration to attend the 2-day conference is now open online.  For complete details, visit the 2021 Virtual Conference section at www.scbio.org.  Registration is free to employees of most SCBIO investors and supporters as well as to students interested in life sciences, while faculty and teachers can attend the entire conference for $25.  General admission tickets are available while they last for as little as $75.  Limited Virtual Exhibit  space and sponsorships are also available by inquiring at info@scbio.org.

    The 2-day conference draws attendees from across America for networking, innovation updates, opportunity discovery, partnership making and strategic discussion.  Already committed attendees include officials across a broad spectrum of life sciences industries including medical devices, bio manufacturing, drug discovery, R&D, pharmaceuticals, diagnostics and testing, digital health and health IT, bio-ag and more. 

    SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry has a $12 billion economic impact in the Palmetto State, with more than 750 firms directly involved and over 43,000 professionals employed directly or indirectly in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products. 

    “Life sciences is a major driver of South Carolina’s economy, and this conference’s growth is testament to the industry’s surging impact, reach and rapidly rising economic significance in our state and region,” noted SCBIO President and CEO Sam Konduros. “Already accounting for thousands of highly-skilled jobs in the Palmetto State, this sector has tremendous growth potential, and we’re excited to virtually showcase the top companies, research universities and leaders from across our state and country at SCBIO 2021.” 

    Among leading biotech and med-tech industry brands participating in the conference are Nephron Pharmaceuticals, BIO, Johnson & Johnson, AVX, PhRMA, Medpoint, AdvaMed, Poly-Med, VWR, Ritedose Corporation, Rhythmlink, SoftBox Systems, ZEUS, Patheon Thermo Fisher, Zverse, Abbott, Alcami and more.  All of South Carolina’s research universities – MUSC, Clemson and the University of South Carolina – are represented, as are major healthcare systems, and economic development entities including the South Carolina Department of Commerce, SCRA, South Carolina Hospital Association and many others.

    As the official state affiliate of BIO, PhRMA and AdvaMed, SCBIO members include academic institutions, biotech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products that transform how we heal, fuel and feed the world.

    For additional information on SCBIO or to register for SCBIO 2021, visit www.SCBIO.org.

  • sam patrick posted an article
    AVX received state's top life sciences award for 2019 see more

    AVX Corporation, a leading manufacturer and supplier of advanced electronic components and interconnect, sensor, control, and antenna solutions, was honored with the South Carolina Life Sciences Pinnacle Award for Organizational Contribution at the 2019 SCBIO Annual Conference, which was held October 29–31 in Greenville, South Carolina. Bestowed by SCBIO Life Sciences Industry, an investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in South Carolina, the distinguished award recognizes AVX’s significant contributions to the advancement of the state’s $11.4 billion life sciences industry, including its vast and ever-expanding portfolio of innovative electronic components and interconnect solutions for high-reliability medical applications.

    “The life sciences industry is a significant driver of South Carolina’s growing knowledge economy,” said SCBIO President and CEO Sam Konduros, “so we’re very pleased to honor AVX as a SCBIO Mission Partner and 2019 award recipient for their exceptional contributions to the advancement of life sciences. AVX has demonstrated a sustained commitment to developing innovative, high-reliability, and high-performance components that have earned the trust of a majority of implantable life support device manufacturers worldwide.”

    With more than 20 years of proven high-reliability performance in the medical industry, AVX is widely recognized as a leading global supplier of medical-grade components, including advanced tantalum and ceramic capacitors, thin film passives, filters, connectors, and multi-pin arrays — all of which are manufactured in ISO 9001 facilities using strict manufacturing control, statistical screening, and testing procedures compliant with rigorous FDA quality and safety regulations. The company’s extensive range of high-reliability medical solutions enables a wide range of both critical and non-critical medical applications, ranging from Class III implantable and life-sustaining devices including pacemakers, implantable cardioverter-defibrillators (ICDs), neurostimulators, neuromodulation devices, and external heart pump controls to Class I and II devices including cochlear implants, insulin pumps, drug pumps, hearing aids, heart monitors, vascular-assist devices, MRI and X-ray machines, external defibrillators, and other patient monitoring and diagnostic devices.

    “We are honored to have been presented with the South Carolina Life Sciences Pinnacle Award for Organizational Contribution by such a valued mission partner as SCBIO,” said Robert Fairey, vice president of the AVX Medical Division. “AVX is dedicated to delivering top-quality, cutting-edge component technologies that meet or exceed the stringent specifications and requirements set forth by the medical industry and is actively engaged in the continued expansion of these highly specialized passive component and interconnect product portfolios.”

    Fairey represented AVX at this year’s SCBIO conference, which provided a record gathering of 450 life sciences industry experts, thought leaders, and executives from 11 countries, 32 states, and nearly every county in South Carolina with valuable information exchange and networking opportunities.

    For more information about AVX, please visit www.avx.com, email inquiry@avx.com, follow them on LinkedIn and Twitter, like them on Facebook, call 864-967-2150, or write to One AVX Boulevard, Fountain Inn, S.C. 29644.

    About AVX
    AVX Corporation is a leading international manufacturer and supplier of advanced electronic components, interconnect, sensing, control, and antenna solutions with 29 manufacturing facilities in 16 countries around the world. AVX offers a broad range of devices including capacitors, resistors, filters, couplers, sensors, controls, circuit protection devices, connectors, and antennas. The company is publicly traded on the New York Stock Exchange (NYSE:AVX).

  • sam patrick posted an article
    SC Commerce's Bobby Hitt, Abbott's Tom Strange, Nephron saluted by SCBIO see more

    Nearly 350 industry leaders on hand to salute inaugural honorees for commitment to advancing South Carolina’s booming life sciences industry

     

     NOVEMBER 2, 2018 – To resounding applause from a record gathering from 4 countries, 22 states and virtually every county in South Carolina, life sciences leaders saluted three leaders – two individuals and one organization – for profound positive impact and exceptional contributions to the advancement of South Carolina’s $11.4 billion life sciences industry.

     South Carolina Secretary of Commerce Robert M. “Bobby” Hitt III was presented with the inaugural South Carolina Life Sciences Hall of Fame Award for his personal championing of the life sciences industry, which today has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products.  SC Commerce is a Founding Partner and strategic supporter of SCBIO, and has been highly instrumental in helping the rapid growth of life sciences in the Palmetto State.

     Mr. Hitt has served as South Carolina Secretary of Commerce since January 2011. Promoting a team-first approach to economic development, Hitt has positioned the S.C. Department of Commerce and its many partners and allies for industry recruitment success. Since 2011, Team South Carolina has recruited more than $35 billion in capital investment and approximately 125,000 new jobs to the state. This year alone, multiple world-class companies have made significant investments in South Carolina, including BMW, Samsung and Volvo Cars.  Before his time as Secretary of Commerce, Hitt served as manager of Corporate Affairs at the BMW Manufacturing Company in Spartanburg County after 17 years as managing editor of The State and Columbia Record newspapers.

     Presented with the inaugural South Carolina Life Sciences Pinnacle Award for Individual Contribution to the industry was Tom Strange, Senior Director of Research & Development for Abbott Labs in Liberty, South Carolina.  With an extensive background in materials science, Mr. Strange holds 48 patents and has authored numerous papers covering all aspects of capacitor development. He began his illustrious career with Philips Components in 1979 leading research activity involving development of capacitors that made thoracic implantable cardioverter defibrillators possible. Today, with over 20 years at St Jude Medical/Abbott, his team continues to define state of the art in implantable medical devices for pacing and arrhythmia correction, neuromodulation and battery performance. 

    Honored for his exceptional industry-related contributions and profound impact on the state, its citizens and the life sciences industry, Mr. Strange led efforts to establish SC Launch!, the public/private initiative with the SC legislature to fund start-up activities in SC under SCRA, and helped to launch SCBIO as an affiliate of the national BIO organization. He holds numerous honors and awards, and earned undergraduate and graduate degrees in Physics from the University of South Carolina.

    Presented with the inaugural South Carolina Life Sciences Pinnacle Award for Organizational Contribution to the industry was Nephron Pharmaceuticals of West Columbia, represented by owners Lou and Bill Kennedy.  A Vision Partner of SCBIO, CEO Lou Kennedy joined Nephron Pharmaceuticals in 2001, and was named President/CEO in 2007. She led the creation of a state of the art manufacturing facility in West Columbia in 2014, and oversaw development of a national sales force which helped Nephron grow by 300% and increased shipped product to over one billion doses annually. 

    Honored for Nephron’s economic, innovation, social and quality of life impact in the state, the Kennedy’s helped establish the Kennedy Pharmacy Innovation Center in conjunction with the USC School of Pharmacy. Ms. Kennedy serves on or chairs numerous boards including those of SCBIO, the SC Chamber of Commerce, the National Bank of South Carolina, and the South Carolina Manufacturers Alliance.

    The three honorees joined BIO global CEO Jim Greenwood and more than 50 additional national speakers at SCBIO 2018 – the annual conference which brought top leaders and executives from life sciences organizations across the state and nation to Charleston, South Carolina October 23-25.

    Included among attendees were scores of top industry chief executives, leaders in government and higher education, biotechnology and pharma executives, clinicians and researchers, and industry supporters from across America including DePuy Synthes Global Orthopedic Leader I.V. Hall, J.P. Morgan Executive Director of Healthcare Investment Banking Bell Zhong, MUSC President David Cole, USC President Harris Pastides, Siemens Healthineers North Americas President Dave Pacitti, and numerous others.

    SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry has an $11.4 billion economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products. 

    “The life sciences industry is a major driver of South Carolina’s economy, and these noted honorees and this conference is testament to the industry’s growing impact, reach and rapidly rising economic significance in our state and region,” noted SCBIO President and CEO Sam Konduros. “We’re pleased to honor them for their many contributions, and salute them for the advances they have facilitated for this industry.”

    As the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations – SCBIO members include hundreds of academic institutions, biotech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products that transform how we heal, fuel and feed the world.

    For additional information on SCBIO, visit www.SCBIO.org.